139 related articles for article (PubMed ID: 24887304)
1. Effects of ranolazine on quality of life among patients with diabetes mellitus and stable angina.
Arnold SV; Kosiborod M; McGuire DK; Li Y; Yue P; Ben-Yehuda O; Spertus JA
JAMA Intern Med; 2014 Aug; 174(8):1403-5. PubMed ID: 24887304
[No Abstract] [Full Text] [Related]
2. Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).
Kosiborod M; Arnold SV; Spertus JA; McGuire DK; Li Y; Yue P; Ben-Yehuda O; Katz A; Jones PG; Olmsted A; Belardinelli L; Chaitman BR
J Am Coll Cardiol; 2013 May; 61(20):2038-45. PubMed ID: 23500237
[TBL] [Abstract][Full Text] [Related]
3. Diabetes and coronary disease: a need for new therapies for an expanding disease burden.
Lew WY; DeMaria AN
J Am Coll Cardiol; 2013 May; 61(20):2046-7. PubMed ID: 23500323
[No Abstract] [Full Text] [Related]
4. Clinical experience with ranolazine in a veteran population with chronic stable angina.
Reeder DN; Gillette MA; Franck AJ; Frohnapple DJ
Ann Pharmacother; 2012 Jan; 46(1):42-50. PubMed ID: 22215689
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of ranolazine added to standard-of-care treatment in patients with chronic stable angina pectoris.
Kohn CG; Parker MW; Limone BL; Coleman CI
Am J Cardiol; 2014 Apr; 113(8):1306-11. PubMed ID: 24560062
[TBL] [Abstract][Full Text] [Related]
6. In regard to the TERISA trial.
Golwala H
J Am Coll Cardiol; 2014 Jul; 64(4):420. PubMed ID: 25060380
[No Abstract] [Full Text] [Related]
7. Reply: In regard to the TERISA trial.
Kosiborod M; Arnold SV; Spertus JA; McGuire DK; Yue P; Ben-Yehuda O; Belardinelli L; Chaitman BR
J Am Coll Cardiol; 2014 Jul; 64(4):420-1. PubMed ID: 25060381
[No Abstract] [Full Text] [Related]
8. Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c.
Arnold SV; McGuire DK; Spertus JA; Li Y; Yue P; Ben-Yehuda O; Belardinelli L; Jones PG; Olmsted A; Chaitman BR; Kosiborod M
Am Heart J; 2014 Oct; 168(4):457-465.e2. PubMed ID: 25262254
[TBL] [Abstract][Full Text] [Related]
9. Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus and Impact on Health Care Resource Utilization and Cardiac Interventions.
Page RL; Ghushchyan V; Read RA; Hartsfield CL; Koch BR; Nair KV
Am J Cardiol; 2015 Nov; 116(9):1321-8. PubMed ID: 26358510
[TBL] [Abstract][Full Text] [Related]
10. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
[TBL] [Abstract][Full Text] [Related]
11. Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes.
Timmis AD; Chaitman BR; Crager M
Eur Heart J; 2006 Jan; 27(1):42-8. PubMed ID: 16176940
[TBL] [Abstract][Full Text] [Related]
12. The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials.
Banon D; Filion KB; Budlovsky T; Franck C; Eisenberg MJ
Am J Cardiol; 2014 Mar; 113(6):1075-82. PubMed ID: 24462341
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Seattle Angina Questionnaire With Daily Angina Diary in the TERISA Clinical Trial.
Arnold SV; Kosiborod M; Li Y; Jones PG; Yue P; Belardinelli L; Spertus JA
Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):844-50. PubMed ID: 25249560
[TBL] [Abstract][Full Text] [Related]
14. Use of ranolazine in patients with stable angina pectoris.
Khera S; Kolte D; Aronow WS
Cardiology; 2014; 128(3):251-8. PubMed ID: 24852049
[TBL] [Abstract][Full Text] [Related]
15. [Ranolazine in the treatment of chronic stable angina].
Gustapane M; Cardillo MT; Biasillo G; Della Bona R
Clin Ter; 2012; 163(3):231-4. PubMed ID: 22964698
[TBL] [Abstract][Full Text] [Related]
16. Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Trial.
Arnold SV; McGuire DK; Spertus JA; Tang F; Yue P; Inzucchi SE; Belardinelli L; Chaitman BR; Kosiborod M
Am Heart J; 2015 Oct; 170(4):753-759.e2. PubMed ID: 26386799
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of ranolazine in patients with chronic stable angina.
Kloner RA; Hines ME; Geunes-Boyer S
Postgrad Med; 2013 Nov; 125(6):43-52. PubMed ID: 24200760
[TBL] [Abstract][Full Text] [Related]
18. Ranolazine for the treatment of refractory angina in a veterans population.
Greene RS; Rangel RM; Edwards KL; Chastain LM; Brouse SD; Alvarez CA; Collins LJ; Brilakis ES; Banerjee S
Cardiovasc Revasc Med; 2012; 13(2):141.e1-5. PubMed ID: 21856249
[TBL] [Abstract][Full Text] [Related]
19. Advances in the management of stable angina.
Trujillo TC
J Manag Care Pharm; 2006 Oct; 12(8 Suppl):S10-6. PubMed ID: 23577423
[TBL] [Abstract][Full Text] [Related]
20. Extended-release ranolazine: critical evaluation of its use in stable angina.
Truffa AA; Newby LK; Melloni C
Vasc Health Risk Manag; 2011; 7():535-9. PubMed ID: 21915171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
